# FDA Inspection 1102691 - Boehringer Ingelheim Pharma Gmbh & Co Kg - September 19, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/db6a02f0-3ebc-4c6a-b689-a50299bdaa08
Source feed: FDA_Inspections

> FDA Inspection 1102691 for Boehringer Ingelheim Pharma Gmbh & Co Kg on September 19, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102691
- Company Name: Boehringer Ingelheim Pharma Gmbh & Co Kg
- Inspection Date: 2019-09-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1208927 - 2022-07-22](https://www.globalkeysolutions.net/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/9de3497b-512b-42a4-ae0e-2d4019f554dd)
- [FDA Inspection 1107587 - 2019-08-15](https://www.globalkeysolutions.net/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/9096c412-3d0c-495a-bc07-117473eca2b6)
- [FDA Inspection 1086418 - 2019-04-05](https://www.globalkeysolutions.net/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/dbf348fc-bd1b-46d8-8ac0-0e7e2889aa61)
- [FDA Inspection 881697 - 2014-05-30](https://www.globalkeysolutions.net/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/a2c6cb01-57e6-4c5e-949b-e480008d9ddd)
- [FDA Inspection 826498 - 2013-03-19](https://www.globalkeysolutions.net/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/b82b9c1c-8e5d-4af2-b32e-7c891abab0fd)

Company: https://www.globalkeysolutions.net/companies/boehringer-ingelheim-pharma-gmbh-co-kg/5b2ffd33-30ee-4e73-bb66-fa96b4549154

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c